CClinicalTrials.gg
CompletedNCT04361864IUR63Updated May 7, 2021

Cross-sectional Survey on Patients With Urinary Tract Infections in Puy-de-Dôme : Epidemiology of Recurrent Urinary Tract Infections and Risk Factors

An observational study in Urinary Tract Infections, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-05-07.

Sponsored by University Hospital, Clermont-Ferrand · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
561
Ages
18 Years and older
Sex
All
01

Study summary

Urinary tract infections (UTI) are an important part of infectious diseases. For some patients, those infections are recurrent and have many consequences such as altered quality of life, recurrent symptoms, antibiotics overuse... The primary purpose of this study is to estimate the proportion of patients in Puy-de-Dôme with recurrent urinary tract infections among patients with at least one UTI during 2019. The secondary purposes are : characteristics of patients with recurrent UTI, by sex ; determine predictive factors of recurrent UTI, by sex ; describe bacterial ecology of recurrent UTI and the proportion of multi-resistant bacteria.

02

Conditions studied

03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's enrollment of 561 is above the median of 240 across 2,136 observational studies indexed under Infections.

Browse Infections studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with at least one urinary tract infection during year 2019

Inclusion criteria

  • patient from 18 years old
  • affiliated to the french healthcare system
  • with at least one urinary tract infection during year 2019
  • has accepted email contact with CPAM 63 (Caisse Primaire d'Assurance Maladie du Puy-de-Dôme)

Exclusion criteria

Exclusion Criteria:

  • pregnancy during year 2019
  • none urinary tract infection reported in 2019
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
561 participants (actual)
Patient registry
No

Groups and cohorts

  • RUTI

    patients with at least 3 episodes of UTI during 2019

  • UTI

    patients with one or two episodes of UTI during 2019

06

What researchers measure

Primary outcomes

  1. Proportion of recurrent urinary tract infections

    Proportion, with its 95% confidence interval, of recurrent urinary tract infections, by sex, in the population of Puy-de-Dôme who reported having had at least one urinary tract infection in the year 2019. The diagnosis of recurrent urinary tract infection will be at least 3 urinary tract infections in one year

    Time frame: During year 2019

Secondary outcomes

  1. age in year

    Risk factors of recurrent urinary tract infections

    Time frame: day 1

  2. sexe

    Risk factors of recurrent urinary tract infections

    Time frame: day 1

  3. , medical and surgical history

    Risk factors of recurrent urinary tract infections

    Time frame: day 1

  4. life habits

    Risk factors of recurrent urinary tract infections

    Time frame: day 1

  5. number of visits at the general practitioner

    measure of healthcare consumption with the number of visits at the general practitioner performed

    Time frame: during year 2019

  6. number of urinalysis

    measure of healthcare consumption with the number of urinalysis performed

    Time frame: during year 2019

  7. number of antibiotic therapies

    measure of healthcare consumption with the number of antibiotic therapies performed

    Time frame: during year 2019

  8. quality of life

    quality of life evaluated with a self-reported questionnaire inspired by the Leicester Impact Scale

    Time frame: during year 2019

  9. bacteriological characteristics of recurrent urinary tract infections

    evaluated with results of urinalysis, bacterial identification and antimicrobial susceptibility

    Time frame: during year 2019

07

Study locations

1 site
  • Chu Clermont Ferrand
    Clermont-Ferrand, 63003, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04361864
Lead sponsor
University Hospital, Clermont-Ferrand
Collaborators
Caisse Primaire d'Assurance Maladie du Puy-de-Dôme
Responsible party
Sponsor
First posted
Apr 24, 2020
Start date
Jan 15, 2021
Primary completion
Feb 1, 2021
Completion
Feb 2, 2021
Last update
May 7, 2021

Study contacts

Olivier Lesens
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion